×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NRIX – nurix therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NRIX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
04:02 pm
nrix
Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia [Yahoo! Finance]
Low
Report
Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia [Yahoo! Finance]
11/20
04:00 pm
nrix
Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
Low
Report
Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
11/17
10:36 am
nrix
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 [Yahoo! Finance]
Medium
Report
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024 [Yahoo! Finance]
11/17
10:30 am
nrix
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
Medium
Report
Nurix Therapeutics Presents Preclinical Data from Two Autoimmune and Inflammatory Disease Programs, NX-5948 and GS-6791, at ACR Convergence 2024
11/6
08:07 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
Medium
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $29.00 price target on the stock.
11/5
09:00 am
nrix
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting
Low
Report
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting
10/31
07:00 am
nrix
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
Nurix Therapeutics to Participate in Upcoming Investor Conferences
10/24
07:16 am
nrix
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $35.00 price target on the stock.
Low
Report
Nurix Therapeutics, Inc. (NASDAQ: NRIX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $35.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
10/11/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
IN-LINE
Report
6.5%
nurix therapeutics, inc. - common stock
7/11/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
MISS
Report
8.1%
nurix therapeutics, inc. - common stock
4/10/2024
07:00 am
nrix
nurix therapeutics, inc. - common stock
BEAT
Report
-12.5%
nurix therapeutics, inc. - common stock
2/15/2024
04:00 pm
nrix
nurix therapeutics, inc. - common stock
MISS
Report
0.2%
nurix therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
09:01 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: Redmile Group, LLC
High
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: Redmile Group, LLC
11/14
04:22 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: BAKER BROS. ADVISORS LP
High
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: BAKER BROS. ADVISORS LP
11/14
04:09 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: SANDS ARTHUR T
High
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: SANDS ARTHUR T
11/14
12:48 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: WASATCH ADVISORS LP
Low
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: WASATCH ADVISORS LP
11/8
10:53 am
nrix
Form SC 13G Nurix Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SC 13G Nurix Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
05:40 pm
nrix
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: MORGAN STANLEY
Low
Report
Form SC 13G/A Nurix Therapeutics, Inc. Filed by: MORGAN STANLEY
11/4
05:48 pm
nrix
Form 4 Nurix Therapeutics, Inc. For: Nov 04 Filed by: Ring Christine
Low
Report
Form 4 Nurix Therapeutics, Inc. For: Nov 04 Filed by: Ring Christine
11/4
04:30 pm
nrix
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Low
Report
Form 144 Nurix Therapeutics, Inc. Filed by: Ring Christine
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: